ApicHope Pharmaceutical Hits Day Low at CNY 32.70 Amid Price Pressure

ApicHope Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 5.87% on June 16, 2026. The stock reached an intraday low of CNY 32.70, reflecting ongoing challenges in its market performance. Over the past week, ApicHope has seen a decrease of 6.06%, while its performance over the last month has been even more pronounced, with a decline of 17.19%. In the context of the broader market, the China Shanghai Composite index has shown a modest decline of just 0.11% today, contrasting sharply with ApicHope's performance. Over the past year, the stock has underperformed significantly, with a staggering loss of 42.36%, while the Shanghai Composite has gained 20.75%. Financial metrics indicate that ApicHope's net sales have contracted at an annual rate of 12.52% over the last five years, and its operating profit has seen a dramatic decline. The company's current valuation reflects a price-to-book ratio of 7.58, alongside a return on equity of 11.51%. Despite these challenges, ApicHope maintains a market capitalization of CNY 14,676 million within the pharmaceuticals and biotechnology sector.